Theratechnologies (NASDAQ:THTX) Shares Down 0.6% – Time to Sell?

Theratechnologies Inc. (NASDAQ:THTX) shares were down 0.6% during trading on Friday . The stock traded as low as $1.69 and last traded at $1.72. Approximately 84,056 shares traded hands during mid-day trading, a decline of 45% from the average daily volume of 153,814 shares. The stock had previously closed at $1.73.

Theratechnologies Stock Performance

The firm has a market capitalization of $79.09 million, a P/E ratio of -17.20 and a beta of 1.30. The company has a 50-day simple moving average of $1.54 and a two-hundred day simple moving average of $1.40.

Institutional Investors Weigh In On Theratechnologies

An institutional investor recently raised its position in Theratechnologies stock. National Bank of Canada FI grew its holdings in shares of Theratechnologies Inc. (NASDAQ:THTX) by 29.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 186,815 shares of the company’s stock after buying an additional 42,435 shares during the period. National Bank of Canada FI owned 0.41% of Theratechnologies worth $232,000 as of its most recent SEC filing.

Theratechnologies Company Profile

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.